MSKCC — New York, New York

Public research footprint of MSKCC, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Chronic Lymphocytic Leukemia · Glypican-3 (GPC3)-Positive Squamous Non-small Cell Lung Cancer · Mature B-Cell Non-Hodgkin Lymphoma · Small Lymphocytic Lymphoma

Recently updated registry entries

NCT03765918 — Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given… (Active Not Recruiting)
NCT05884398 — A Study of an Intermittent ADT Approach With Apalutamide Monotherapy in Participants With… (Active Not Recruiting)
NCT07028853 — This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at MSKCC?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.